Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D F Ma

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Blood Advances|December 4, 2018
Working together: establishment of the first national hematopoietic stem cell transplantation (HSCT) center in Sri LankaP Abeysinghe, L Morawaka, S Gunasekara, et al.
International Journal of Laboratory Hematology|May 29, 2018
CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometryY S Ting, S A B C Smith, D A Brown, et al.
Leukemia|May 17, 2003
Successful peripheral blood stem cell mobilisation with filgrastim in patients with chronic myeloid leukaemia achieving complete cytogenetic response with imatinib, without increasing disease burden as measured by quantitative real-time PCRC H Hui, K Y Goh, D White, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Blood Advances|December 4, 2018
Working together: establishment of the first national hematopoietic stem cell transplantation (HSCT) center in Sri LankaP Abeysinghe, L Morawaka, S Gunasekara, et al.
International Journal of Laboratory Hematology|May 29, 2018
CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometryY S Ting, S A B C Smith, D A Brown, et al.
Leukemia|May 17, 2003
Successful peripheral blood stem cell mobilisation with filgrastim in patients with chronic myeloid leukaemia achieving complete cytogenetic response with imatinib, without increasing disease burden as measured by quantitative real-time PCRC H Hui, K Y Goh, D White, et al.
Pageof 2